Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
Women with epilepsy taking antiepileptic drugs during pregnancy have been shown to have an increased risk of having a child with a major malformation. There is some recent evidence to suggest that these drugs may also affect cognitive and behavioural development. Epilepsy is a common neurological condition and women with epilepsy constitute a significant number of pregnancies in the UK each year. Some of the drugs used to treat epilepsy are increasingly being used in the treatment of migraine and other pain syndromes and also in psychiatry principally for the control of bipolar affective disorder. This article looks at the evidence currently available in assessing the safety of the individual agents used in pregnancy.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1517/14740338.4.5.869 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!